Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia

Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia

Addition of the immunomodulator pentoxifylline (PTX) to antimonial treatment of mucosal leishmaniasis has shown increased efficacy. This randomized, double-blind, placebo-controlled trial evaluated whether addition of pentoxifylline to meglumine antimoniate (MA) treatment improves therapeutic respon...

Full description

Bibliographic Details
Main Authors: Maria del Mar Castro, Alexandra Cossio, Adriana Navas, Olga Fernandez, Liliana Valderrama, Lyda Cuervo-Pardo, Ricardo Marquez-Oñate, María Adelaida Gómez, Nancy Gore Saravia
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Pathogens
Subjects:
cutaneous leishmaniasis
pentoxifylline
meglumine antimoniate
clinical trial
Online Access:https://www.mdpi.com/2076-0817/11/3/378

Internet

https://www.mdpi.com/2076-0817/11/3/378

Similar Items